In The News Posted January 29, 2019 Share Posted January 29, 2019 PARIS, January 29, 2019 /PRNewswire/ -- Valneva is a leading European biotech company specialized in innovative vaccines. Thomas Lingelbach, President & CEO of Valneva, comments on the Group's strategy. Watch video interview and read transcript:... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.